Blood Pressure Drug Shows Effectiveness Against Antibiotic-Resistant Bacteria

A common blood pressure medication demonstrates effectiveness against methicillin-resistant Staphylococcus aureus (MRSA), according to research published in Nature Communications. The discovery offers hope in combating antibiotic-resistant bacteria, which cause over 2.8 million infections and more than 35,000 deaths annually in the United States. These drug-resistant infections are notoriously difficult to treat with conventional antibiotics. The blood pressure drug could serve as the basis for new treatments, representing a potential breakthrough in addressing one of modern medicine's most pressing challenges.

Antibiotic-Resistant Bacteria as a Public Health Crisis

• ▪Antibiotic-resistant bacteria are responsible for more than 35,000 deaths in the U.S. each year.
• ▪Infections from antibiotic-resistant bacteria are difficult to treat.
• ▪Antibiotic-resistant bacteria are responsible for over 2.8 million infections in the U.S. each year.

Blood Pressure Drug as Potential MRSA Treatment

• ▪A blood pressure drug shows effectiveness against methicillin-resistant Staphylococcus aureus.
• ▪A study in Nature Communications reports that a blood pressure drug could be the basis of a treatment for methicillin-resistant Staphylococcus aureus.

Perspective of Researchers studying antibiotic alternatives

• ▪Repurposing existing blood pressure medications could provide a faster pathway to treating antibiotic-resistant infections than developing new antibiotics.
• ▪The blood pressure drug represents a potential new weapon against drug-resistant infections.

1 source